Clinical Strategies for Serious Infection: A North American Perspective

This publication has 22 references indexed in Scilit:

• Comparative In Vitro Activity of Meropenem Versus Other Extended-Spectrum Antimicrobials Against Randomly Chosen and Selected Resistant Clinical Isolates Tested in 26 North American Centers
  Clinical Infectious Diseases, 1997
• Comparison of Antibacterial Activities of Meropenem and Six Other Antimicrobials Against Pseudomonas aeruginosa Isolates from North American Studies and Clinical Trials
  Clinical Infectious Diseases, 1997
• The Most Frequent Aminoglycoside Resistance Mechanisms--Changes with Time and Geographic Area: A Reflection of Aminoglycoside Usage Patterns?
  Clinical Infectious Diseases, 1997
• Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance Program
  Clinical Infectious Diseases, 1996
• Efficacy of Cefepime in the Treatment of Infections Due to Multiply Resistant Enterobacter Species
  Clinical Infectious Diseases, 1996
• Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic Investigation
  The Journal of Infectious Diseases, 1996
• Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis
  JAMA, 1995
• Ceftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
  The Journal of Infectious Diseases, 1994
• Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States
  Infection Control & Hospital Epidemiology, 1992
• Resistance to Imipenem in Pseudomonas aeruginosa: Clinical Experience and Biochemical Mechanisms
  Clinical Infectious Diseases, 1988